ACTIVE

NUTRIFARMA

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result194,3 k €+19,2 %over 1 year

Gross margin648,1 k €+19,7 %over 1 year

Equity1,4 M €+7,2 %over 1 year

Workforce4,6 ETP+12,2 %over 1 year

Identity

Source · BCE/KBO

NUTRIFARMA is a Public limited company incorporated in 1996. Its main activity is: Wholesale of other food, including fish, crustaceans and molluscs. Its registered office is in Heist-op-den-Berg. It employs on average 4,6 ETP workers (FTE).

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0458.087.349
Incorporation: 04/06/1996
Legal form: Public limited company
Registered office: Cederstraat 18 box A
2220 Heist-op-den-Berg · FlandreSee on map
Contributed capital: 1 308 351,00 €
Latest accounts: 31/12/2025
Average workforce: 4,6 ETP

Activities (NACE)

46389Wholesale of other food, including fish, crustaceans and molluscs· main 46389Wholesale of other food, including fish, crustaceans and molluscs 46460Wholesale of pharmaceutical goods 46460Wholesale of pharmaceutical goods 51384Air transport 51460Air transport+3

Joint committees (3)

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 20 filings

Trend over 20 financial years

	2025		2024		2023		2022		2021
Income statement
Gross margin	648,1 k €	+19.7%	541,3 k €	-1.7%	550,4 k €	+32.5%	415,3 k €	-29.1%	585,8 k €
EBITDA	220,3 k €	+25.4%	175,7 k €	+5.2%	167,1 k €	+186%	58,4 k €	-76.3%	246,7 k €
Operating result	213,7 k €	+25.0%	171 k €	+3.4%	165,4 k €	+195%	56,2 k €	-77.1%	245,6 k €
Net result	194,3 k €	+19.2%	163,1 k €	+3.7%	157,3 k €	+213%	50,3 k €	-78.9%	238,4 k €
Balance sheet
Equity	1,4 M €	+7.2%	1,3 M €	+14.3%	1,1 M €	+16.0%	980,8 k €	+289%	252,2 k €
Total assets	1,8 M €	+16.6%	1,5 M €	+3.1%	1,5 M €	+27.0%	1,2 M €	+145%	482,6 k €
Cash	529,4 k €	+193%	180,9 k €	-8.6%	197,9 k €	+315%	47,7 k €	-18.3%	58,4 k €
Debts	407,3 k €	+66.8%	244,1 k €	-31.9%	358,6 k €	+79.9%	199,3 k €	-12.9%	228,8 k €
Other
Workforce	4,6 ETP	+12.2%	4,1 ETP	+7.9%	3,8 ETP	-20.8%	4,8 ETP	-5.9%	5,1 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€

See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

4 active · 5 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
CORPOROS0536.228.866Represented by Johan Rosvelds	Directorsince 14/02/2022
DEMACOM0468.632.635Represented by Johan Rosvelds	Directorsince 22/10/2015
JP ENTERPRISES0478.862.571Represented by Johan Picard	Directorsince 14/02/2022
MYLLON CONSULT0873.624.560Represented by Katrien Mylle	Directorsince 14/02/2022

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Charles De Stoop	Director12/05/2017 → 2020 accounts
FPMC0885.179.438Represented by Michèle Cloet	Director22/10/2015 → 2015 accounts
EMILAR0457.921.855Represented by Johan Rosvelds	Director2015 accounts

Other companies at this address

Cederstraat 18 2220 Heist-op-den-Berg

Company	CBE no.
1eye● Active	0830.712.651
EMILAR● Active	0457.921.855
Immo - Haacht● Active	0421.253.875
IMMONIUM● Active	0860.621.315

Full financial information

Source · NBB

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	11/06/2026	14/07/2025	10/07/2024	31/07/2023	12/07/2022	26/07/2021
General meeting	15/05/2026	24/06/2025	28/06/2024	30/06/2023	30/06/2022	30/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 20 filings

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	15/05/2026	11/06/2026	Dutch	PDF
Abridged model	31/12/2024	24/06/2025	14/07/2025	Dutch	PDF
Abridged model	31/12/2023	28/06/2024	10/07/2024	Dutch	PDF
Abridged model	31/12/2022	30/06/2023	31/07/2023	Dutch	PDF
Abridged model	31/12/2021	30/06/2022	12/07/2022	Dutch	PDF
Abridged model	31/12/2020	30/06/2021	26/07/2021	Dutch	PDF
Micro model	31/12/2019	17/09/2020	08/10/2020	Dutch	PDF
Abridged model	31/12/2018	30/06/2019	30/07/2019	Dutch	PDF
Abridged model	31/12/2017	29/06/2018	26/07/2018	Dutch	PDF
Micro model	31/12/2016	29/06/2017	25/08/2017	Dutch	PDF
Abridged model	31/12/2015	27/06/2016	26/07/2016	Dutch	PDF
Abridged model	31/12/2014	30/06/2015	31/08/2015	Dutch	PDF
Abridged model	31/12/2013	27/09/2014	30/09/2014	Dutch	PDF
Abridged model	31/12/2012	24/09/2013	10/10/2013	Dutch	PDF
Abridged model	31/12/2011	29/08/2012	26/09/2012	Dutch	PDF
Abridged model	31/12/2010	31/08/2011	30/09/2011	Dutch	PDF
Abridged model	31/12/2009	31/08/2010	30/09/2010	Dutch	PDF
Abridged model	31/12/2008	30/06/2009	07/08/2009	Dutch	PDF
Abridged model	31/12/2007	30/06/2008	31/07/2008	Dutch	PDF
Abridged model	31/12/2006	29/06/2007	20/07/2007	Dutch	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

4 active · 5 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
CORPOROS0536.228.866Represented by Johan Rosvelds	Directorsince 14/02/2022
DEMACOM0468.632.635Represented by Johan Rosvelds	Directorsince 22/10/2015
JP ENTERPRISES0478.862.571Represented by Johan Picard	Directorsince 14/02/2022
MYLLON CONSULT0873.624.560Represented by Katrien Mylle	Directorsince 14/02/2022

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Charles De Stoop	Director12/05/2017 → 2020 accounts
FPMC0885.179.438Represented by Michèle Cloet	Director22/10/2015 → 2015 accounts
EMILAR0457.921.855Represented by Johan Rosvelds	Director2015 accounts

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Mandates16/02/2022
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN
PDF
Mandates14/07/2017
Ontslag en benoeming bestuurders
PDF
Mandates03/07/2017
Ontslag en benoeming bestuurders
PDF
Other12/07/2016
STATUTENWIJZIGING |
PDF
Other10/11/2015
STATUTENWIJZIGING
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts

Year

Identity

Incorporation

Name

Registered office

Annual accounts

Filings20 filings

Mandates

DEMACOM

JP ENTERPRISES

CORPOROS

MYLLON CONSULT

Charles De Stoop

FPMC

EMILAR

Philippe Rosvelds

Johan Rosvelds

1996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202420252026

NUTRIFARMA

Cederstraat 18 bte A, 2220 Heist-op-den-Berg

Director

CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE

Registered address	Period	Source
Cederstraat 18 bte A, 2220 Heist-op-den-BergCurrent	accounts 2021 → 2025	Accounts 2025 · 2026-00159377

Company names

Source · NBB annual accounts, CBE

Name	Period	Source
NUTRIFARMACurrent	accounts 2021 → 2025	Accounts 2025 · 2026-00159377

Events

2025
Annual accounts 2025194,3 k €↑
2024
Annual accounts 2024163,1 k €↑
2023
Annual accounts 2023157,3 k €↑
2022
Annual accounts 202250,3 k €↓
2021
Annual accounts 2021238,4 k €↑
2020
Annual accounts 2020230,1 k €↑
2019
Annual accounts 2019-81,5 k €↑
2018
Annual accounts 2018-212,3 k €↑
2017
Annual accounts 2017-394,4 k €↓
2016
Annual accounts 2016-309,1 k €↓
2015
Annual accounts 201518,4 k €↑
2014
Annual accounts 2014-5,7 k €↑
2013
Annual accounts 2013-38,9 k €↑
2012
Annual accounts 2012-48,6 k €↓
2011
Annual accounts 201115,3 k €↑
2010
Annual accounts 2010-6,2 k €↑
2009
Annual accounts 2009-47,2 k €↓
2008
Annual accounts 20081,1 k €↑
2007
Annual accounts 2007-107,8 k €↓
2006
Annual accounts 200616,5 k €
04/06/1996
IncorporationPublic limited company

NUTRIFARMA

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline

Registered offices

Company names

Events